Cambrex Aktie

Cambrex is a small molecule company that offers drug substance, drug product, and analytical services. The company provides an end-to-end partnership for the research, development, and manufacture of small molecule therapeutics at every stage of the lifecycle. With years of experience and a growing team of experts servicing global clients, the company is tried and trusted in branded and generic markets for API and dosage form development and manufacturing. It was founded on 1981 and is headquartered in East Rutherford, New Jersey.